Skip to main content
Erschienen in: Supportive Care in Cancer 6/2009

01.06.2009 | Original Article

Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation

verfasst von: Brian D. Badgwell, Kerrington Smith, Ping Liu, Eduardo Bruera, Steven A. Curley, Janice N. Cormier

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

We sought to determine the clinical presentation, management, and outcomes associated with surgical consultation for symptom palliation in oncology inpatients.

Materials and methods

We reviewed the medical records of inpatients for whom surgical consultations were requested (January 2000 to September 2006) at a tertiary referral cancer center to identify those who underwent surgical palliative evaluation (defined as consultation for symptoms attributable to an advanced or incurable malignancy). We used the Cox proportional hazards model to identify prognostic factors associated with overall survival (OS) and logistic regression to identify factors associated with surgical intervention.

Results

Surgical consultation was requested for 1,102 inpatients; 442 (40%) met the criteria for surgical palliative evaluation. Gastrointestinal obstruction was the most common complaint (43%), while wound complications/infection and gastrointestinal bleeding accounted for 10% and 8%, respectively. The median OS was 2.9 months. Adverse prognostic factors for OS included ≥2 radiologically evident disease sites (HR = 1.4; 95% CI, 1.1–1.8) and carcinomatosis/sarcomatosis (HR = 1.4; 95% CI, 1.1–1.7). Palliative surgical procedures were performed in 119 (27%) patients, with a 90-day morbidity and mortality rate of 40% and 7% respectively. Patients with wound complications (OR = 3.3; 95% CI, 1.4–7.6), intestinal obstruction (OR = 1.9; 95% CI, 1.1–3.2), or an intact primary/recurrent tumor (OR = 3.6; 95% CI, 2.2–6.0) were more likely to undergo surgical intervention. Patients with ascites were less likely to undergo surgery (OR = 0.4; 95% CI, 0.2–0.8).

Conclusions

Surgical palliative evaluations accounted for 40% of inpatient surgical consultations. Given that OS in this population is short and surgery is associated with considerable morbidity and mortality, non-operative management is desirable.
Literatur
1.
Zurück zum Zitat A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987–994. doi:10.1056/NEJM199309303291402 A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987–994. doi:10.​1056/​NEJM199309303291​402
2.
Zurück zum Zitat American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta
3.
Zurück zum Zitat World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva
4.
Zurück zum Zitat Cox D (1972) Regression models and life tables (with discussion). J Roy Stat Soc Ser B 34:187–220 Cox D (1972) Regression models and life tables (with discussion). J Roy Stat Soc Ser B 34:187–220
6.
Zurück zum Zitat Feuer DJ, Broadley KE, Shepherd JH et al (1999) Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 75:313–322. doi:10.1006/gyno.1999.5594 PubMedCrossRef Feuer DJ, Broadley KE, Shepherd JH et al (1999) Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 75:313–322. doi:10.​1006/​gyno.​1999.​5594 PubMedCrossRef
9.
Zurück zum Zitat Krebs HB, Goplerud DR (1983) Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 61:327–330PubMed Krebs HB, Goplerud DR (1983) Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 61:327–330PubMed
18.
Zurück zum Zitat Miner TJ, Brennan MF, Jaques DP (2004) A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 240:719–726PubMed Miner TJ, Brennan MF, Jaques DP (2004) A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 240:719–726PubMed
20.
Zurück zum Zitat Podnos YD, Juarez G, Pameijer C et al (2007) Impact of surgical palliation on quality of life in patients with advanced malignancy: results of the decisions and outcomes in palliative surgery (DOPS) trial. Ann Surg Oncol 14:922–928. doi:10.1245/s10434-006-9238-y PubMedCrossRef Podnos YD, Juarez G, Pameijer C et al (2007) Impact of surgical palliation on quality of life in patients with advanced malignancy: results of the decisions and outcomes in palliative surgery (DOPS) trial. Ann Surg Oncol 14:922–928. doi:10.​1245/​s10434-006-9238-y PubMedCrossRef
22.
Zurück zum Zitat Turnbull AD, Guerra J, Starnes HF (1989) Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol 7:381–386PubMed Turnbull AD, Guerra J, Starnes HF (1989) Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol 7:381–386PubMed
Metadaten
Titel
Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation
verfasst von
Brian D. Badgwell
Kerrington Smith
Ping Liu
Eduardo Bruera
Steven A. Curley
Janice N. Cormier
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0554-6

Weitere Artikel der Ausgabe 6/2009

Supportive Care in Cancer 6/2009 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.